propafenone has been researched along with Acute Generalised Exanthematous Pustulosis in 1 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conforti, C | 1 |
| di Meo, N | 1 |
| Giuffrida, R | 1 |
| Retrosi, C | 1 |
| Vezzoni, R | 1 |
| Romita, P | 1 |
| Bussani, R | 1 |
| Zalaudek, I | 1 |
1 other study available for propafenone and Acute Generalised Exanthematous Pustulosis
| Article | Year |
|---|---|
Acute generalized exanthematous pustulosis caused by propafenone: An emerging skin adverse reaction.
Topics: Acute Generalized Exanthematous Pustulosis; Humans; Propafenone; Skin | 2020 |